Effect of Immunosuppression in Risk of Developing Generalized Symptoms in Ocular Myasthenia Gravis: A Retrospective Cohort Study.
Deepak MenonMohammed AlharbiHans D KatzbergVera BrilMeg G MendozaCarolina Barnett-TapiaPublished in: Neurology (2024)
This study provides Class III evidence that treatment of OMG with corticosteroids or nonsteroidal immunosuppressants reduces the risk of generalization.